Ledger.Open graph →
SEC Form D · filed April 13, 2015

Matinas BioPharma Holdings, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEDMINSTER, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jerome A. Jabbour · Bedminster, NJExecAbdel A. Fawzy · Bedminster, NJExecGary A. Gaglione · Bedminster, NJExecDouglas F. Kling · Bedminster, NJExecHerbert A. Conrad · Bedminster, NJDirectorStefano A. Ferrari · Bedminster, NJDirectorRoelof Rongen · Bedminster, NJExec · DirectorJames F. Scibetta · Bedminster, NJDirectorAdam A. Stern · Bedminster, NJDirectorSean Dalton · Boston, MAExecJay Leon · Seattle, WAExec · DirectorCapital Management LLC Glenville · Greenwich, CTDirectorAdam D. Egelberg · Greenwich, CTExecGeorge Bobotas · Tarpon Springs, FLExecEllen Rubin · Boston, MAExec · DirectorPaula Long · Boston, MADirectorJitendra Saxena · Boston, MAExec · DirectorDavid Orfao · Boston, MAExec · DirectorLazarus Vekiarides · Boston, MAExec · DirectorMantford C. Hawkins · Fort Worth, TXDirectorRay A. Smith · Irvine, CAExecMing Shan · Menlo Park, CADirectorXuecheng Jin · Menlo Park, CAExecGeorge Bobotas · Bedminster, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗